Author:
Johansen Truls E. Bjerklund,Zahl Per-Henrik
Publisher
Norwegian Medical Association
Reference5 articles.
1. Van Poppel H, Albreht T, Basu P et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol 2022; 19: 562–72. [PubMed][CrossRef]
2. Jani C, Mouchati C, Abdallah N et al. Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database. Prostate Cancer Prostatic Dis 2022; 0. doi: 10.1038/s41391-022-00628-0. [PubMed][CrossRef]
3. Bertuccio P, Santucci C, Carioli G et al. Mortality Trends from Urologic Cancers in Europe over the Period 1980-2017 and a Projection to 2025. Eur Urol Oncol 2021; 4: 677–96. [PubMed][CrossRef]
4. Berge V, Baco E, Karlsen SJ. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results. Scand J Urol Nephrol 2010; 44: 223–7. [PubMed][CrossRef]
5. Johansen TB, Greene D, Breen D et al. red. Handbook of Focal Therapy for Prostate and Renal Cancer. London: JP Medical, 2016.